| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/21/2002 | WO2002022162A1 Remedies for amyotrophic lateral sclerosis |
| 03/21/2002 | WO2002022161A2 The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
| 03/21/2002 | WO2002022160A2 The diagnosis, prevention, amelioration and/or treatment of disturbed immune function induced by disturbed lipid metabolism |
| 03/21/2002 | WO2002022159A1 Thionin as an antineoplastic and immunostimulant |
| 03/21/2002 | WO2002022158A1 Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities |
| 03/21/2002 | WO2002022156A2 Topical formulations for delivery of interleukin-11 |
| 03/21/2002 | WO2002022155A1 Immunogenic composition of hepatitis c and methods of use thereof |
| 03/21/2002 | WO2002022154A2 Pharmaceutical compositions for sustained drug delivery |
| 03/21/2002 | WO2002022153A2 Use of a polypeptide comprising the extracellular domains of il-20rb for the treatment of inflammation |
| 03/21/2002 | WO2002022152A2 Use of deltorphin a and/or dermorphin h for protection against ischemia and reperfusion injury |
| 03/21/2002 | WO2002022151A2 Use of glp-1 and flp-2 peptides for treatment of bone disorders |
| 03/21/2002 | WO2002022150A2 Medicament containing activated antithrombin iii |
| 03/21/2002 | WO2002022149A1 Use of il-6r/il-6 chimera in huntington's disease |
| 03/21/2002 | WO2002022138A1 Antibacterial agents and methods of identification |
| 03/21/2002 | WO2002022133A1 Promotion of adoptosis in cancer cells by co-administration of cyclin dependent kinase inhibitors and cellular differentiation agents |
| 03/21/2002 | WO2002022107A2 Pharmaceutical composition having modified carrier |
| 03/21/2002 | WO2002022088A1 Hair nourishments and method of screening the same |
| 03/21/2002 | WO2002022080A2 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 03/21/2002 | WO2002022077A2 Compositions and methods for inhibition of hiv-1 infection |
| 03/21/2002 | WO2001098324A8 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 03/21/2002 | WO2001096388A8 Compositions and methods for the therapy and diagnosis of colon cancer |
| 03/21/2002 | WO2001087982A3 Immunotoxin fusion proteins and means for expression thereof |
| 03/21/2002 | WO2001087039A3 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2 |
| 03/21/2002 | WO2001081545A3 Regulation of gene expression by hspbp1 |
| 03/21/2002 | WO2001080829A3 Taste masking coating composition |
| 03/21/2002 | WO2001079267A3 A glycopeptide and preparation thereof |
| 03/21/2002 | WO2001079193A3 Substituted hydrazinyl heteroaromatic inhibitors of thrombin |
| 03/21/2002 | WO2001078760A3 Method for treating pain by peripheral administration of a neurotoxin |
| 03/21/2002 | WO2001077341A3 Mammalian heparanase |
| 03/21/2002 | WO2001077289A3 Polynucleotides encoding novel secreted proteins |
| 03/21/2002 | WO2001076631A3 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia |
| 03/21/2002 | WO2001075041A3 A novel polypeptide-human epilepsy-associated protein 11 and the polynucleotide encoding said polypeptide |
| 03/21/2002 | WO2001075003A3 A NOVEL POLYPEPTIDE, A HUMAN UTERUS PROTEIN ASSOCIATED WITH A cpn 60 26 MOLECULE AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE |
| 03/21/2002 | WO2001074994A3 A novel peptide - human tnfr/nger protein 13 which contains cytochrome c structure domain and the polynucleotide coding this novelpeptide |
| 03/21/2002 | WO2001074902A3 Adenine binding g protein coupled receptors |
| 03/21/2002 | WO2001074847A3 T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancer |
| 03/21/2002 | WO2001074379A3 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors |
| 03/21/2002 | WO2001072841A3 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 03/21/2002 | WO2001072322A3 High dosage parenteral administration of lactoferrin |
| 03/21/2002 | WO2001070672A3 Compounds and methods to treat alzheimer's disease |
| 03/21/2002 | WO2001068859A3 Il-17 receptor like molecules and uses thereof |
| 03/21/2002 | WO2001068854A3 Fibroblast growth factor-like molecules and uses thereof |
| 03/21/2002 | WO2001068125A3 Methods and compositions for the treatment and prevention of erectile dysfunction |
| 03/21/2002 | WO2001068123A3 Monocyte chemoattractant activity of galectin-3 |
| 03/21/2002 | WO2001066771A3 Human serine protease |
| 03/21/2002 | WO2001066763A3 23436, a human ubiquitin protease family member and uses thereof |
| 03/21/2002 | WO2001066757A8 25934, a novel fatty acid desaturase and uses therefor |
| 03/21/2002 | WO2001066748A3 Full length expressed human polynucleotides and the polypeptides they encode |
| 03/21/2002 | WO2001064840A8 Novel bone marrow nucleic acids and polypeptides |
| 03/21/2002 | WO2001064837A3 β NETRIN AND USES THEREOF |
| 03/21/2002 | WO2001064715A3 Memno peptides, a process for their preparation and their use |
| 03/21/2002 | WO2001064344A3 Microfabricated devices for the storage and selective exposure of chemicals and devices |
| 03/21/2002 | WO2001062942A3 MATERIALS AND METHODS INVOLVING HYBRID VASCULAR ENDOTHELIAL GROWTH FACTOR DNAs AND PROTEINS AND SCREENING METHODS FOR MODULATORS |
| 03/21/2002 | WO2001062905A3 Integrin antagonists |
| 03/21/2002 | WO2001062725A3 Methods and compositions for inhibiting angiogenesis |
| 03/21/2002 | WO2001060991A3 Human kinases |
| 03/21/2002 | WO2001060990A3 Sphingosine kinases |
| 03/21/2002 | WO2001058954A3 Trade molecules and uses related thereto |
| 03/21/2002 | WO2001058934A3 Kahalalide f and related compounds |
| 03/21/2002 | WO2001055411A3 Human sulfatases |
| 03/21/2002 | WO2001051638A3 Drug metabolizing enzymes |
| 03/21/2002 | WO2001051513A3 Ovarian tumor-associated sequences |
| 03/21/2002 | WO2001051510A3 G-csf conjugates |
| 03/21/2002 | WO2001049835A3 Molecules that influence pathogen resistance |
| 03/21/2002 | WO2001049775A3 Antisense antibacterial cell division composition and method |
| 03/21/2002 | WO2001047469A3 Treatment of ischemic brain injuries with brain targetted antioxidant compounds |
| 03/21/2002 | WO2001045670A3 A stable immunogenic composition for frozen storage |
| 03/21/2002 | WO2001042295A3 Clasp-7 transmembrane protein |
| 03/21/2002 | WO2001041812A3 Amphiphilic polymers and polypeptide conjugates comprising same |
| 03/21/2002 | WO2001040465A3 Compositions and methods for the treatment of immune related diseases |
| 03/21/2002 | WO2001040275A3 Peptides that stabilize protein antigens and enhance presentation to cd8+ t cells |
| 03/21/2002 | WO2001037779A3 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 03/21/2002 | WO2001036635A3 Neurite outgrowth-promoting factor homologue and nucleic acids encoding same |
| 03/21/2002 | WO2001035943A3 Dextrose and insulin fluid formulation for intravenous infusion |
| 03/21/2002 | WO2001032872A3 Twik potassium channel molecules and uses therefor |
| 03/21/2002 | WO2001031009A3 Chandra: a th1-specific gene |
| 03/21/2002 | WO2001030375A3 Use of gdnf for treating corneal defects |
| 03/21/2002 | WO2001026736A3 Intraspinal compositions containing botulinum toxin for treating pain |
| 03/21/2002 | WO2001012855A3 Binary encoded sequence tags |
| 03/21/2002 | WO2001010199A9 A knockout mouse for the tumor suppressor gene anx7 |
| 03/21/2002 | WO2000041484A8 Novel use of phospholipids of vegetable and animal origin in nutritional therapy |
| 03/21/2002 | US20020035737 Cloning pigs using donor nuclei from differentiated cells |
| 03/21/2002 | US20020035734 Binding protein for use in the treatment of neutropenia, infections and cancer |
| 03/21/2002 | US20020035356 Prophylactic and therapeutic treatment of the ductal epithelium of a mammary gland for cancer |
| 03/21/2002 | US20020035246 SMAD-interacting polypeptides and their use |
| 03/21/2002 | US20020035244 Reagents and methods useful for detecting diseases of the prostate |
| 03/21/2002 | US20020035243 Drug complexes |
| 03/21/2002 | US20020035242 Antibody binding |
| 03/21/2002 | US20020035240 Novel mammalian cell cycle protein |
| 03/21/2002 | US20020035239 Active materials for grampositive bacteria, antibiotic resistance infections |
| 03/21/2002 | US20020035115 Thrombin inhibitors |
| 03/21/2002 | US20020035097 Method of preventing and treating chemotherapy-induced alopecia |
| 03/21/2002 | US20020035083 CRF2 ligands in combination therapy |
| 03/21/2002 | US20020035081 Nucleic acid encoding a polypeptide of the virus' core protein having altered carboxyterminus, for reducing replication of a wild type hepadnavirus, by a dominant negative mechanism |
| 03/21/2002 | US20020035080 Proliferation potential proteins (P2P), involved in RNA processing; repressing the proliferative potential of a cell with an antisense oligonucleotide that binds to a domain of the open reading frame of P2P cDNA |
| 03/21/2002 | US20020035079 Mutated cyclin G1 protein |
| 03/21/2002 | US20020035066 Methods to improve neural outcome |
| 03/21/2002 | US20020035065 Selective MMP inhibitors having reduced side-effects |
| 03/21/2002 | US20020035064 Method for treating atherosclerosis employing an aP2 inhibitor and combination |
| 03/21/2002 | US20020035063 Derivatives of laspartomycin and preparation and use thereof |